Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies.

Katrincsakova, Beata; Takeda, Haruko; Urbankova, Helena; Michaux, Lucienne; Jarosova, Marie; Vandenberghe, Peter; Georges, Michel; Charlier, Carole; Wlodarska, Iwona

doi:10.4161/epi.4.7.9924

Article (Scientific journals)

Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies.

Katrincsakova, Beata; Takeda, Haruko; Urbankova, Helena et al.

2009 • In Epigenetics, 4 (7), p. 469-75

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/102250

DOI
10.4161/epi.4.7.9924

PubMed
19786834

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

KatrincsakovaEPI4-7.pdf

Publisher postprint (7.85 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Alleles; Base Sequence; Chromosomes, Human, Pair 14; Female; Genes, Immunoglobulin Heavy Chain; Humans; Intercellular Signaling Peptides and Proteins/analysis/genetics/metabolism; Leukemia, B-Cell/genetics/immunology/metabolism; Lymphoma, B-Cell/chemistry/genetics/immunology/metabolism; Male; Membrane Proteins/analysis/genetics/metabolism; Methylation; Parents; Proteins/analysis/genetics/metabolism

Abstract :

[en] Leukemias/lymphomas with IGH-involving del(14q)(1) commonly lose the DLK1-GTL2 imprinted domain that comprises several paternally and maternally expressed genes, including a cluster of microRNAs. Given that deletion of this region could lead to inactivation of a monoallelically expressed tumor suppressor gene, our study aimed at determination of the parental origin of del(14q/IGH). The designed allele-specific methylation study of the DLK1/GTL2 intergenic differentially methylated region allowed us to determine the parental origin of del(14q/IGH) in 9/20 analyzed cases. In six cases del(14q/IGH) was of the paternal origin and in three cases of the maternal origin. These findings argue against the concept that a TSG/anti-oncomir located in the imprinted region is systematically inactivated by a targeted deletion of its functional allele.

Disciplines :

Genetics & genetic processes

Author, co-author :

Katrincsakova, Beata

Takeda, Haruko ; Université de Liège - ULiège > Département de productions animales > GIGA-R : Génomique animale

Urbankova, Helena

Michaux, Lucienne

Jarosova, Marie

Vandenberghe, Peter

Georges, Michel ; Université de Liège - ULiège > Département de productions animales > GIGA-R : Génomique animale

Charlier, Carole

Wlodarska, Iwona

Language :

English

Title :

Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies.

Publication date :

2009

Journal title :

Epigenetics

ISSN :

1559-2294

eISSN :

1559-2308

Publisher :

Landes Bioscience, United States

Volume :

Issue :

Pages :

469-75

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 10 November 2011

Statistics

Number of views

77 (3 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Pospisilova H, Baens M, Michaux L, Stul M, Van Hummelen P, Van Loo P, et al. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007; 21:2079-83.
Debiec-Rychter M, Sciot R, Pauwels P, Schoenmakers E, Dal Cin P, Hagemeijer A. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors. Genes Chromosomes Cancer 2001; 32:26-32.
Wylie AA, Murphy SK, Orton TC, Jirtle RL. Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res 2000; 10:1711-8.
miRBase [database on the Internet]. Wellcome Trust Sanger Institute, Hinxton Cambridge UK. [cited 10-9-2008]. Available from: http://microrna.sanger. ac.uk.
Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, et al. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12 Nat Genet 2003; 35:97-102.
Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, et al. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005; 92:1574-80.
Sakajiri S, O'kelly J, Yin D, Miller CW, Hofmann WK, Oshimi K, et al. Dlk1 in normal and abnormal hematopoiesis. Leukemia 2005; 19:1404-10.
Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet 2006; 15:821-30.
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by MEG3 noncoding RNA. J Biol Chem 2007; 282:24731-42.
Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, et al. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008; 93:4119-25.
Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaillé J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 2004; 14:1741-8.
Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008; 105:7004-9.
Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9:435-43.
Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008; 27:378-86.
Dalmay T. MicroRNAs and cancer. J Intern Med 2008; 263:366-75.
Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008; 22:1095-105.
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99:15524-9.
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353:1793-801.
Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27:2240-52.
Paige AJ. Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Cell Mol Life Sci 2003; 60:2147-63.
Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 2007; 315:642-5.
Sherry ST, Ward M, Sirotkin K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 1999; 9:677-9. Available from: http://www.ncbi.nlm.nih.gov/SNP.
Ge B, Gurd S, Gaudin T, Dore C, Lepage P, Harmsen E, et al. Survey of allelic expression using EST mining. Genome Res 2005; 15:1584-91.
Takeda H, Caiment F, Smit M, Hiard S, Tordoir X, Cockett N, et al. The callipyge mutation enhances bidirectional long-range DLK1-GTL2 intergenic transcription in cis. Proc Natl Acad Sci USA 2006; 103:8119-24.
Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2005; 137:12-23.